StockData
Solesence, Inc. logo

Solesence, Inc. (SLSN) stock

SLSNNasdaqPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/301% above fair value
$1.69+0.09 (+5.62%)

Close on Nov 17, 2026Market cap $119.39MP/E –Yield –

Solesence r&d expenses

Research and development expenses are spending on new products and technology.

Solesence's R&D Expenses for the twelve months ending Jun 30, 2026 was $4.11M, up 1.8% year over year. For fiscal 2025 it was $4.09M, up 6.6% from the year before. Over ten years it grew 12.4% a year on average. The highest annual figure on record is $4.09M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.09M+6.6%
FY2024Dec 31, 2024$3.84M0.0%
FY2023Dec 31, 2023$3.84M+26.3%
FY2022Dec 31, 2022$3.04M+35.9%
FY2021Dec 31, 2021$2.24M+42.3%
FY2020Dec 31, 2020$1.57M-16.0%
FY2019Dec 31, 2019$1.87M-9.1%
FY2018Dec 31, 2018$2.06M+18.5%
FY2017Dec 31, 2017$1.74M+11.7%
FY2016Dec 31, 2016$1.55M+22.1%
FY2015Dec 31, 2015$1.27M-4.9%
FY2014Dec 31, 2014$1.34M-20.3%
FY2013Dec 31, 2013$1.68M+3.2%
FY2012Dec 31, 2012$1.63M-6.3%
FY2011Dec 31, 2011$1.74M+7.6%
FY2010Dec 31, 2010$1.61M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$947.00K-0.8%
Q1 FY2026Mar 31, 2026$1.04M+2.4%
Q4 FY2025Dec 31, 2025$1.04M-5.1%
Q3 FY2025Sep 30, 2025$1.08M+11.5%
Q2 FY2025Jun 30, 2025$955.00K+10.5%
Q1 FY2025Mar 31, 2025$1.02M+11.9%
Q4 FY2024Dec 31, 2024$1.09M+39.0%
Q3 FY2024Sep 30, 2024$970.00K-8.2%
Q2 FY2024Jun 30, 2024$864.00K-12.8%
Q1 FY2024Mar 31, 2024$910.00K-9.3%
Q4 FY2023Dec 31, 2023$785.00K+8.0%
Q3 FY2023Sep 30, 2023$1.06M+24.6%
Q2 FY2023Jun 30, 2023$991.00K+24.3%
Q1 FY2023Mar 31, 2023$1.00M+50.6%
Q4 FY2022Dec 31, 2022$727.00K+28.7%
Q3 FY2022Sep 30, 2022$848.00K+33.5%
Q2 FY2022Jun 30, 2022$797.00K+48.7%
Q1 FY2022Mar 31, 2022$666.00K+33.5%
Q4 FY2021Dec 31, 2021$565.00K+29.3%
Q3 FY2021Sep 30, 2021$635.00K+56.8%
Q2 FY2021Jun 30, 2021$536.00K+50.1%
Q1 FY2021Mar 31, 2021$499.00K+34.1%
Q4 FY2020Dec 31, 2020$437.00K+4.0%
Q3 FY2020Sep 30, 2020$405.00K-17.0%
Q2 FY2020Jun 30, 2020$357.00K-26.4%
Q1 FY2020Mar 31, 2020$372.00K-22.0%
Q4 FY2019Dec 31, 2019$420.00K-22.8%
Q3 FY2019Sep 30, 2019$488.00K+17.3%
Q2 FY2019Jun 30, 2019$485.00K-9.9%
Q1 FY2019Mar 31, 2019$477.00K-14.5%
Q4 FY2018Dec 31, 2018$544.00K+42.4%
Q3 FY2018Sep 30, 2018$416.00K-15.8%
Q2 FY2018Jun 30, 2018$538.00K+13.0%
Q1 FY2018Mar 31, 2018$558.00K+45.3%
Q4 FY2017Dec 31, 2017$382.00K-22.7%
Q3 FY2017Sep 30, 2017$494.00K+28.0%
Q2 FY2017Jun 30, 2017$476.00K–
Q1 FY2017Mar 31, 2017$384.00K–
Q4 FY2016Dec 31, 2016$494.00K–
Q3 FY2016Sep 30, 2016$386.00K–

More Solesence figures

See a number that looks wrong?